Detalhe da pesquisa
1.
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Lancet Oncol
; 25(3): 317-325, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342115
2.
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res
; 26(1): 20, 2024 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297352
3.
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer.
Breast Cancer Res Treat
; 204(2): 289-297, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155272
4.
Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer.
Cancer
; 128(23): 4085-4094, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210737
5.
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II-III and metastatic breast cancers.
Breast Cancer Res Treat
; 194(1): 65-78, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482127
6.
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
Breast Cancer Res Treat
; 189(3): 641-651, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417675
7.
Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
Breast Cancer Res Treat
; 181(2): 383-390, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318957
8.
Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program.
Breast J
; 26(9): 1688-1694, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32875655
9.
Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
Breast J
; 26(3): 384-390, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31448540
10.
Prevalence of germline variants in inflammatory breast cancer.
Cancer
; 125(13): 2194-2202, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30933323
11.
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
Breast Cancer Res Treat
; 176(2): 303-310, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004299
12.
Inflammatory Breast Cancer: a Separate Entity.
Curr Oncol Rep
; 21(10): 86, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414257
13.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
N Engl J Med
; 372(2): 134-41, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564897
14.
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.
Oncologist
; 22(1): 25-32, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789775
15.
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
Ann Surg Oncol
; 24(9): 2563-2569, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28560598
16.
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.
Oncologist
; 26(8): e1483, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978307
17.
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).
Breast Cancer Res Treat
; 160(2): 297-304, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27704226
18.
Inflammatory breast cancer and development of brain metastases: risk factors and outcomes.
Breast Cancer Res Treat
; 151(1): 225-32, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25893587
19.
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
Breast Cancer Res Treat
; 151(3): 589-96, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981899
20.
Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.
Ann Surg Oncol
; 22(8): 2483-91, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25791789